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Background: Benefit sharing in health research has been the focus of international debates for many years, particularly
in developing countries. Whilst increasing attention is being given to frameworks that can guide researchers to
determine levels of benefits to participants, there is little empirical research from developing countries on the practical
application of these frameworks, including in situations of extreme poverty and vulnerability. In addition, the voices
of those who often negotiate and face issues related to benefits in practice - frontline researchers and fieldworkers
(FWs) - are rarely included in these debates. Against this background, this paper reports on experiences of negotiating
research participation and benefits as described by fieldworkers, research participants and researchers in two community
based studies.
Methods: The findings reported here are from a broader social science study that explored the nature of interactions
between fieldworkers and participants in two community based studies on the Kenyan Coast. Between January and
July 2010, data were collected using participant observation, and through group discussions and in-depth interviews
with 42 fieldworkers, 4 researchers, and 40 study participants.
Results: Participants highly appreciated the benefits provided by studies, particularly health care benefits. Fieldworkers
were seen by participants and other community members as the gatekeepers and conduits of benefits, even though
those were not their formal roles. Fieldworkers found it challenging to ignore participant and community requests for
more benefits, especially in situations of extreme poverty. However, responding to requests by providing different sorts
and levels of benefits over time, as inadvertently happened in one study, raised expectations of further benefits and led
to continuous negotiations between fieldworkers and participants.
Conclusions: Fieldworkers play an important intermediary role in research; a role imbued with multiple challenges and
ethical dilemmas for which they require appropriate support. Further more specific empirical research is needed to
inform the development of guidance for researchers on benefit sharing, and on responding to emergency humanitarian
needs for this and other similar settings.
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There are numerous challenges in conducting research in
developing countries. An area that has attracted particular
attention in recent years is the study benefits that should
be offered to participants and their communities, and to
the population living in and around the geographical area
in which the research is being conducted. It is widely
accepted that research should be locally relevant, and that
benefits should outweigh risks for the participants and
communities involved [1]. However, there is a great deal
of debate about what counts as a benefit, and on levels
and types of benefits Lairumbi et al. (2011) reviewed 7
international and 9 country-specific (Africa) ethics guide-
lines with a focus on benefit sharing in resource poor
settings [2]. They summarise the main debates on
benefit-sharing including in relation to: who is receiving
the benefits i.e. participants, communities, international
community/society; when the benefits are provided (framed
on a continuum of time of during and after the research);
and the different forms of benefits and who is responsible
for their provision [2]. The authors point out that while
guidelines are supposed to provide broad normative direc-
tives, there are discrepancies in approaches to benefits
across these guidelines with “obvious potential to result in
differing practical interpretations of the ethical conduct of
global health research” ([2] p6).
A useful categorisation of benefits by King (2000) distin-
guishes between direct benefits to participants (therapeutic
benefits from the intervention being studied), indirect or
collateral benefits to participants (benefits as a result of be-
ing a research participant e.g. free health care) and aspir-
ational benefits from the results of research [3]. These
forms of benefits are not mutually exclusive, with some
overlaps between direct and indirect benefits. There is,
however, some lack of clarity on whether compensation for
inconveniences and costs, and the provision of ancillary
care – that is, care which research participants need but
which is not necessary “to answer the research question
nor avoid or mitigate harm resulting from participation in
the research” ([4], p0709) - should be seen as a form of
benefit or as researchers’ responsibilities.
The Fair Benefits framework, developed by researchers
working in research institutions in developing countries in
2001, recommends a broad view of what should count as
benefits, to include (direct and indirect/collateral) benefits
to participants and populations during and after research
[5]. In this account, the range of potential direct and
collateral benefits are considered not only to be clinical,
but to also include employment, capacity building, long
term collaboration and financial rewards from research
results. The framework sets out the nature of relationship
between research institutions and the host population as
collaborative. This concept of collaborative partnership
between researchers and populations hosting research isseparately expounded in Emanuel et al.’s 2004 paper [6].
Commentators have criticised the fair benefits model for
being unclear about how resulting bargains can satisfy
certain substantive conditions of fairness [7] or for being
weak on how negotiating parties can be assumed to have
equal power [8].
Even with these frameworks, teasing out the form, na-
ture and magnitude of benefits that should be considered
for participants and host populations for a given study or
set of studies is a complex process due to competing inter-
ests of research and priority needs of community [9]. In
addition, whether researchers and research institutions
have any responsibility beyond the remit of their research
is a point of contention. Lavery et al. (2010) present a
‘relief from oppression’ guiding principle to aid researchers
working in socio-economically disadvantaged populations
[10]. This guiding principle concerns researchers’ respon-
sibilities to address unmet needs related to background in-
equities by relating researcher responsibilities to the
strength of the researcher-community relationship. They
further make an argument for a humanitarian response –
a moral obligation to respond to situations that exacerbate
vulnerability of communities [10]. The relief of oppression
guiding principle may be an additional useful framework
for researchers working in socio-economically disadvan-
taged populations where there are background injustices
of unmet health needs, poverty, and significant levels of
disease. However, there are relatively few empirical studies
from developing countries on how well these frameworks
might work in practice.
Fieldworkers, who are at the frontline of research
conduct, may face these issues most starkly and most
frequently. Fieldworker (FW) is a term often used in our
setting to refer to community members employed in re-
search activities to assist in accessing and following-up
participants, and in giving consent information [11,12].
Employing FWs from a community can in itself be
described as part of the indirect benefits of a study for
communities, and can facilitate mutual understanding
between research centres and their communities [13-15].
However, employment of FWs in research activities is
not without challenges. A growing body of literature
indicates that fieldworkers’ interface position and roles
can present significant ethical challenges and dilemmas
including how to respond when faced with overwhelm-
ing unmet health care and other needs in the commu-
nity. There can be potential for fieldworkers to breach
confidentiality, and to exploit participants’ trust to meet
recruitment quotas [15,16]. For research in many devel-
oping countries, lack of guidelines on appropriate levels
of benefits, and on how to respond to ethical dilemmas
that FWs and other frontline research staff face, could
leave them in emotionally and materially vulnerable
positions [17].
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search negotiations and participation, as a key theme
that emerged from a broader social science descriptive
study that explored the nature of interactions between
FWs and participants in community based studies. The
social science research was developed around two on-
going community-based studies conducted at the KEMRI-
Wellcome Trust research Programme (KWTRP).
Study site: KEMRI-Wellcome Trust Research Programme
The KEMRI-Wellcome Trust Research Programme
(KEMRI-WT) is a biomedical research centre established
in 1989 in Kilifi on the Kenyan Coast. A range of studies
are carried out in the research centre including laboratory-
based research studies, clinical, psychology, epidemiology,
immunology, entomology, public health, and social and
behavioural research (http://www.kemri-wellcome.org/).
The community of nearly 260,000 residents living in
and around the Kilifi County Hospital form the catchment
area for many research activities at the centre [18]. The
main activities and offices of KEMRI-WT are physically
located in and around the Kilifi County Hospital, with
research and treatment activities conducted in tandem. A
branch of the research centre is strategically located in
Nairobi to feed research into appropriate government pol-
icy arms.
In an effort to ensure adequate standards of diagnosis
and treatment particularly for the paediatric population -
and more recently for the adult population - a collabora-
tive working arrangement with the County level Ministry
of Health (MoH) in the county underpins long-term stra-
tegic support. KEMRI-WT boosts clinical services and
infrastructural development for all patients using the
health facilities in which research is conducted, regardless
of that patients’ involvement in research. Discussion with
MOH staff before the start of studies is aimed at ensuring
that clinical services required for studies are provided in a
way that is not undermining of the health care system. For
example the research centre might provide additional sup-
port to the MOH in terms of drugs and health personnel
in the health facilities where research is happening in
order to avoid generating differences in services between
participants and non-participants. These efforts, aimed at
minimising potential for undue inducement - an excessive
offer too good or large to potentially cloud judgement of
risky research [19] - are not widely described by the re-
search Programme to the local communities because of
concern that community members may feel obligated to
reciprocate by participating in research.
All studies conducted by the programme are approved
by the national scientific and ethics review committees in
addition to institutional - and where necessary external -
scientific and ethics review [20]. A comprehensive commu-
nity engagement strategy [21] includes programme-wideand study specific programs. These are led and coordinated
by a team of community facilitators - the community
liaison group. For studies with a community engagement
component, a study- specific community engagement ad-
visory team (CAST – Communication Advice for Studies)
is constituted. The main roles of the CAST group are to
advise and provide support for study community engage-
ment activities, and to discuss communication issues that
arise during study conduct. Members of CAST group are
drawn from the study team (with the principal investigator
as the chairperson), the community liaison group, social
science researchers and at least one fieldworker (FW) or
FW supervisor from the study team.
In the Programme, discussions on the nature and range
of benefits have been guided primarily by international
guidelines and long-term experiences of researchers work-
ing in the area. Relatively recently, there have been efforts
to begin to develop institutional guidelines on research
benefits. To this end, there is an on-going study focused
on study benefits (the ‘benefits study’). The ‘benefits study’
involves in-depth “deliberative” consultations with a range
of stakeholders including community members and field-
workers, the initial findings are reported elsewhere [22],
and further data collection and analysis are on-going. The
study reported in this paper is a separate one which
explored the challenges that fieldworkers face in their
day-to-day fieldwork activities. Negotiating research par-
ticipation with potential participants, and the centrality of
benefits in those negotiations, was an emerging theme.
This means that there are issues raised in this paper that
could not be explored in detail at the time. However, these
issues will be taken up in more in-depth on the on-going
‘benefits study’.
Fieldworkers are the largest group of staff at the re-
search centre, forming nearly a third of the staff (243 FWs
out of 772 staffa) [12]. Fieldworkers are salaried employees
of the research centre. They are often recruited from the
community where a study is on-going, often the catch-
ment area of approximately 260,000 people living in the
area surrounding the county hospital (the Kilifi Health
and Demographic Surveillance System; KHDSS). With the
main roles of communicating about studies, undertaking
consent processes and following-up participants at their
homes, it is inevitable that fieldworkers are often drawn
into negotiations about research participation and benefits
with potential participants, and with other community
members. The way in which study benefits play out in
these negotiations is important in understanding how
FWs undertake their roles, the type of ethical challenges
they face, and how they could be supported.
Methods
The broader social science qualitative study, in which the
theme of research benefit negotiations emerged, aimed to
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research participants in community-based studies, the
challenges that fieldworkers faced, and if and how these
challenges were resolved. The research was developed
around two on-going community based studies, details of
which are summarised in Table 1. The two case studies
were:
 An observational basic science study involving entire
household (n = 50 households) looking at transmission
patterns of respiratory syncytial virus (RSV) in the
households; referred to as the RSV-study; and
 A malaria vaccine trial involving 900 children
divided into two groups, 6–12 weeks and 5–17
months; referred to as the Malaria-study.
The two case studies were in geographically different
localities, with the RSV-study located within the KHDSS
and the Malaria-study outside the KHDSS, about 30 km
from Kilifi County Hospital. A total of 36 FWs and 6
Senior FWsb were employed in the two case studies. All
the FWs came from and resided within the study popu-
lation, and the majority were male (7/10 and 25/26 in
the RSV and Malaria-study respectively). Their main
roles included sharing initial information with potentialTable 1 Key features of the two community based case studie
Feature The RSV-study
Study question/objective Define and quantify who acquires
from whom in relation to transmis
respiratory syncytial virus (RSV) in
households.
Study design Basic science descriptive study.
Study period Oct 2009 – June 2010; participant
involvement for 6 months.
Number of study sites One site in KEMRI-WT, Kilifi.
Study area in Kilifi One location, 15 kms from the Kili
Hospital (KCH), within KHDSS.
Composition of study team A total of 16 team members;
• 10 FWs, 2 data entry clerks, one e
clinician, coordinator, PI and senior
• Team also included shared staff (
technicians, drivers) with other p
Participants Entire household in a defined geo
locality; household - where memb
in the same compound and with a
eating arrangement e.g. share mea
from the same kitchen. HH selecte
an infant born after previous RSV e
and at least one elder sibling.participants and carrying out follow-up activities. FWs
in the Malaria-study were also involved in identifying and
recruiting participants, since the study was conducted in
an area without a Demographic Surveillance System. The
fieldworkers in the RSV-study were more actively involved
in data collection than those in the Malaria-study, as
shown in Table 2.
Table 3 shows the direct and indirect benefits to par-
ticipants, and indirect benefits to the wider community
that were provided in the two case studies. While health
care was provided to all participants (all household
members in RSV-study and participating children in the
Malaria-study), the level and distribution of benefits
differed in the two studies. For example all illnesses
(acute illnesses such as diarrhoea, fever; and the first
referral visit for chronic such as HIV) were covered for
participants in the Malaria-study, while only acute
illnesses were covered in the RSV-study. These differ-
ences in benefit levels had been planned and approved in
view of different levels of risks and inconveniences, and
different designs of the two studies; a phase III clinical
trial with immediate therapeutic benefits to participants
(Malaria-study), and a basic science study involving
the entire household (RSV-study) with no immediate




Evaluate the efficacy of a ‘promising’ malaria
candidate vaccine against malaria disease in
infants and children, and across diverse malaria
transmission settings in Africa; aimed to address
key safety and efficacy information required for
vaccine licensure.
Double blind (observer blind), randomized,
controlled, multi-centre study.
2008 – 2013 (later extended to 2015); participant
involvement for 34 months.
Eleven sites in seven African countries.
fi County Three administrative divisions, 30 kms from
KCH, 5 locations, in Kilifi County.
Minimum of 47 staff;
ach SFW,
researcher,
• 36 FWs, 3 SFWs, 3 clinicians, 2 Medical officers,




• Team also included shared staff (data entry








Children aged 6-12 weeks and 5-17 months at
first vaccination; 16,000 children across the 11
sites, a minimum of 6,000 in each of the age
category;
For Kilifi site, allocated total of 900 children,
600 and 300 in the 5-17 months 6-12 weeks
group respectively.
Table 2 Study procedures and FW roles in the two case studies
The RSV-study The Malaria-study
Study procedures Follow-up visits at home every 3-4 days; data from
each HH member collected at each visit included:
Randomisation to one of three groups
• Temperature, • Experimental malaria vaccine and its booster at 1.5 years
• Nasopharyngeal flocked swab (NFS), • Experimental malaria vaccine and a different
• Respiratory illness signs and symptoms, • Booster dose of either Meningitis and
• Respiratory rate taken for all children under 5 years, • Septicaemia vacci;ne; and
• Three doses of rabies vaccine plus a different booster
doses of Meningitis and septicaemia;
Procedures
• Oral swab (taken at alternate visits (once-a-week). • Initial physical examination, medical history, anthropometric
tests, temperature.
• Three vaccine doses each a month apart, and
A demographic and risk assessment questionnaire
administered at beginning and end of the study.
• booster dose at 34 months.
• 5 scheduled blood samples over 3 years; each 2.5mls.
• Monitoring of minor and serious adverse events; immediate
post-vaccination and over time.
• 6 consecutive follow-up visits post-vaccination at home.
Monitoring of minor and serious adverse events.
• Referral to nearest health facility for common illnesses,
and to KCH for serious illnesses as advised by attending
clinician.
Fieldworkers roles FWs Carried out all the study procedures at the
households.
FWs Undertook the following roles:
• Home follow-up visits to monitor minor and serious
adverse events.
• Where necessary, made referrals to the health facilities.
• Organised for transport and food for all those attending
the health facility
• On rota at the local healthy facilitate to assist with
anthropometric measures, temperature, and keeping
of research data records
• Followed-up research defaulters.
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propriate levels of compensation for inconveniences
(to entire households) and for discomfort from taking
of nasal swabs. They requested, and were given permis-
sion by the ERC, to determine the details of types and
levels of compensation in consultation with the com-
munity liaison group, researchers at the research
centre and with community leaders at the time of
implementing the study. Fieldworkers were not ex-
pected to negotiate for study benefits with participants
during initial consent processes or over the course of
the studies, although this was not openly stated by re-
searchers, primarily because there was an assumption
that fieldworkers would not do this. When asked about
benefits by participants, FWs were guided to explain as
is written in the informed consent forms (see Table 4).
Social scientists carrying out this study were independ-
ent of the case study research teams, although the PIs of
the case studies (PN and PM) contributed to study designand writing of this manuscript. DK had over 8 years of
managing and coordinating community engagement activ-
ities, and training and providing support to fieldworkers at
the research centre, with support from SM and VM. The
knowledge and experience gained through being involved
in the institution in this way were important in shaping
the overall research and being aware of the context of the
different perspectives of researchers, fieldworkers, and
community members.
The main data collection methods used were partici-
pant observation, natural and focus group discussions
and individual interviews.
Participant observation
Participant observation aimed to provide first-hand infor-
mation on the context in which FWs worked and the type
and nature of interactions between FWs and households.
DK carried out participant observation in both case stud-
ies for a total of 4 months in the RSV-study and 1 month
Table 3 Anticipated risks and benefits in the two case studies
The RSV-study The Malaria-study
Risks • Mild discomfort during NFS taking. • Detailed side effects - as is typical of vaccine trials -
provided in the study protocol and informed consent,
• Time inconveniences. • Include severe (such as convulsions, diarrhoea) and
mild events (e.g. pain, swelling at vaccination site).
Benefits For participants: For participants:
• Free medical care for all common illnesses (such as
diarrhoea, fever regardless of cause, acute respiratory
illness etc) during study.
• Free health care for all routine illnesses (e.g. pneumonia,
diarrhoea, URTI), vaccine related or otherwise, injuries),
throughout the study period (about 3 years), and 1st visit
of chronic illnesses (such as sickle cell disease, HIV, epilepsy).
This includes:
• Clinical visits to every participating household once
a month at home.
• Free referral for specialized treatment where required,
all costs at government facilities covered while transport
is provided for first visit to non-government facilities;
• Other benefits/token staggered throughout the study
period included two chairs to each household, sweets,
educational materials and token1 at end of study.
• All transport to and from the hospital provided by the
study team;
• Meals provided for participant and accompanying
parents/guardian for all clinic visits;
Community benefits: Communal benefits:
• Boosting of three health facilities where the study is
based; renovation of existing buildings, providing
equipment; boosting of health staff, provision of
essential drugs,
• Boosting local health services through provision of
drugs, additional clinical staff.
• Water treatment for all communal water points.
• Provision of emergency medical aid during cholera
epidemic including drugs, staff, referrals.
1Token given at the end of the study were said to be the study teams appreciation to participants for having persevered until the end of the study. They included
educational materials, food items, and clothes to family members.
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ings in the RSV-study and the Malaria-study respectively.
She visited 19 (out of 47) households in the RSV-study,
and 30 (out of 160c) participant households in the
Malaria-study, and accompanied all the 10 FWs on se-
lected days in the RSV-study and 9/36 FWs in the
Malaria-study in their daily work in communities.
Group discussions (natural and focus) and in-depth
interviews
Table 5 summarises the number of interviews held and
the type of respondents involved. A total of 11 focus
group discussions (FGDs) with 64 respondents, 5 natural
group discussions with 16 respondents and 7 in-depth
interviews with 4 different respondents were held.
Table 6 shows the checklist used to guide discussions
with community participants and fieldworkers. Areas
relevant to this paper discussed with participants in the
two case studies included: how decisions to enrol, join
and stay (or withdraw) in research were arrived at; who
within the household was consulted about participation
and what was considered; and what challenges partici-
pants faced while participating in the research, including
who received what benefits at the household and how
they felt about it. For interviews with study teams - PIs,
study coordinatorsd, SFWs and FWs - topics covered in-
cluded: factors that facilitated recruitment and retentionof participants into studies; factors that contributed to
low recruitment and withdrawals from the research;
challenges that study team members faced in conducting
the research; and strategies, if any, they used to address
the challenges. Data collection continued until a point of
saturation where no new themes emerged. All interviews
were tape-recorded, transcribed verbatim, and translated
in to English.
Respondent-households in the RSV-study were se-
lected from the 19 households DK had previously
visited during her participant observation. In this way,
DK was not a total stranger and had some idea of the
household dynamics. Within this group, households
were purposively selected to reflect diversity based on
gender (including female and male-headed households)
and household arrangements (extended and nuclear
families). Respondent-households in the Malaria-study
were purposively selected from the geographical area
surrounding each of the three health facilities in which
the trial was being conducted based on age-group of
child. FGDs were held separately with male and female
respondents in the Malaria-study to address sensitivities
around gender roles and household decision-making
for researche. In both case studies, discussions were
held with the study team members separately; that is
fieldworkers and senior fieldworkers, study coordina-
tors and principal investigators.
Table 5 Summary of interview methods and respondents
Interview type Respondents
In-depth interviews (IDI) 6 IDIs with RSV-study researchers, two
each with PI, Study coordinator,
Senior FW
1 IDI with one FW in the Malaria-study
Natural group discussions 5 Natural (household) group discussions
with 16 adults participating in the
RSV-study
Focus group discussions (FGD) 3 FGDs with 10 FWs in the RSV-study
(one group interviewed twice)
3 FGDs with 26 Field workers in the
Malaria-study
4 FGDs with 24 participants (grouped
per gender) in the Malaria-study
1 FGD with 5 SFW in the Malaria-study
Box 1: Explanation in informed consent forms (ICFs) about benefits2 Name of
vaccine cannot be disclosed as permission not granted by the pharmaceutical
company to do so.
Table 4 Explanation in informed consent forms (ICFs)
about benefits
Case Study Explanation in informed consent forms
RSV-study Aspiration benefit of the research
A vaccine is not yet available to prevent RSV infection but
is under development. In order to know which group to
target for vaccination in future when that vaccine
becomes available, we need to know how the virus is
spread within the community. We aim to closely monitor
respiratory infections within members of the household in
order to understand who transmits the RSV infection to
young children.
Are there any advantages to me/my child if we participate?
(immediate benefits to participants)
You/your child will benefit from close monitoring for any
illness by a nurse during the home visits and will be
referred to the health centre for further consultation and
treatment where necessary. Medical expenses for
outpatient treatment of acute illnesses will be paid for and
where applicable transport costs and treatment at the Kilifi
District Hospital will be met by KEMRI. These benefits will




Aspirational benefit of the research
Malaria is a common and serious disease in young
children that results in many deaths. This study is a test of
a new vaccine called (name of vaccine*) to see if it can
prevent malaria. If the experimental vaccine works, then it
might become part of the routine program of
immunization in Africa. To date, there is no licensed
vaccines to prevent malaria, the experimental malarial
vaccine (name) is still being tested because it’s not known
how well it will work in preventing malaria.
Even if your child takes part in the study, you must
continue to follow the methods you normally use to
prevent malaria in your family. Sleeping under an
insecticide treated bed net with no holes in it can help
protect against malaria. And if your child becomes ill, you
should seek medical care as soon as possible.
Are there any benefits to me/my child for taking part?
(immediate benefits to participants)
If your child takes part in the study, and receives the first
vaccination, he/she will receive medical care from the day
of the first dose of vaccine until the completion of the
study. This care will include treatment of any symptoms
caused by the vaccine or injuries related to the study
procedures, as well as treatment for any acute illnesses
during the study period and free of charge. Treatment of
chronic (long-term) illnesses/injuries unrelated to the study
or study procedure will not be paid for by the study. If
your child is found to have such illnesses/injuries, he/she
will be treated under the existing government services/
programs. If your child has a medical problem that cannot
be treated at the nearest health centre, we will refer him/
her to colleagues at an appropriate clinic. If this were to
happen, we will arrange transport for the first visit to see
the doctor. All transport to and from the hospital will be
provided by the study team so it should not cost you any
money to let your child take part in the trial. You will not
receive any direct payment just for participating in this
study
*Name of vaccine cannot be disclosed as permission not granted by the
pharmaceutical company to do so.
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pants in the language they were most comfortable with.
All participants, apart from one household, gave consent
and signed consent forms for the research. The one
household where consent was not provided, we think,
was because one of the two senior women was reluctant
to participate. The participant who did not provide con-
sent was not interviewed and data was not collected
from this household.
To safeguard participants’ privacy and confidentiality,
all individual identifiers were removed, and codes were
used instead of names in transcripts and in this
manuscript.
Data analysis
We used a combined inductive and deductive approach
to data analysis. An initial framework for analysis was
developed around key areas of interest and objectives
of the research. This framework was revised through
open coding of the data, and themes and concepts gen-
erated from the coded data [23]. Data analysis started
as soon as the initial interviews were transcribed and
cleaned, and continued throughout the study. All
cleaned transcripts were uploaded into Nvivo Version
8.0, the software used to organize and manage the data.
We chose the most informative fieldworker FGD tran-
script for initial open coding, as it would provide the
most variable themes and categories [24]. Data under
each open code were grouped into descriptive themes,
and codes were merged, deleted and created as more
transcripts were added [25]. Initial codes were com-
pared with those of an independent researcher and dif-
ferences resolved through discussion and referring to
the transcript. For each theme, charts were made across
Table 6 Questionnaire guides used in interviews with
participants and fieldworkers in RSV-study
Group discussion with participants in case studies
Decision making on study participation
1 When did you join the study (RSV-study)? How did you come to
know about the study?
2 Since the study involved the whole family:
• how did you know about the study (who informed you about
the study, when and where)
• How did you make the decision to participate? (who was
consulted in the family before the decision to participate was
made, why were they consulted
• Who was not consulted and why not? ( Prompt for
communication within the family, who was involved in making
the decision and why; who was not involved and why;
• What contributed to your decision to join the study?
3 How long did you participate in the study for (a short while then
dropped, continued to end of study etc.);
• What made you participate to the end of the study?
• Did any of the HH members change their decisions as the study
continued? Why? How did you handle this? (probe: how they
communicated about their decision)
• Did any of the HH members drop out of the study and why?
What did other HH members feel about this decision? What was
done about the decision (e.g. accepted by the study team, talked
out of decision)
4 What were some of the most difficult/challenges that you faced
while participating in the study (prompt for:
• Study related e.g. procedures, fears around nasal swabbing (e.g.
why they were afraid of the nasal swabs), any other
• Study benefits and who received these, and how they felt about
them
• HH challenges around continued participation e.g. time
involvement, school going children,
• Study team related issues e.g. frequency of FW visits
• Dealing with non-participating community members.
5 How were these challenges overcome? – by who,
• any consultations with the HH members,
• What was the FWs/study team involvement in resolution (prompt
for whether FWs took extra steps to ensure the issues/challenges
were resolved) etc.
End of study discussion:
6 Now that the study has ended,
• What are your views/opinions about the study?
• What are your views about the FWs and the study team (i.e. how
did they handle any of the questions and challenges that
participants faced).
• Did you face any issues with community members who were not
participating? What issues, how did you handle them? Why do
you think those issues arose?
Future participation in KEMRI research:
7 In future if invited to participate in a KEMRI research, would you
participate, why/why not? What would you consider in making that
decision?
8 Any recommendations?
Table 6 Questionnaire guides used in interviews with
participants and fieldworkers in RSV-study (Continued)
Interviews with fieldworkers in the RSV-study
Changes in study since last FGD:
1 Since the last time we talked, did any of the study procedures
change? Did any of your FW roles change, if yes, why and in what
ways; what were the implications of such changes?
End of study discussion:
2 The HH study ended two weeks ago, what activities are you
currently involved in?
3 The last time we discussed, you were not very sure that the study
will progress to end. Now that it has ended:
• How do you feel the study performed? Was it a success? In what
ways? Did it fail in some ways?
• Overall what are your views about the study?
4 The study overall has been a success in retaining participants to the
end;
• What contributed to such success? (Prompt for what changed in
the study so it progressed to the end successfully? How study
benefits contributed? How relationship with FWs and study
team/researchers contributed)
• What do you think was your contribution in making this study a
success?
• Did you have HH that withdrew from the study? How many and
how did you handle this?
• Did you have HH that wanted to withdraw and did not? How
many and what happened till they did not withdraw?
• Did you have HH that wanted to re-join the study? How did you
handle this?
• Overall what worked well in this study?
• Overall what did not work so well, how was this addressed (e.g.
FW support system etc.)
5 On reflections, what was the most challenging situation you faced
in this study? How was it handled? What was your role in resolving
it? What are your opinions about the way it was resolved?
6 Performance chart for each FW was introduced as the study
progressed, what are your views about it? Is this something that
other teams can use?
7 Now that the study has come to an end; how do you feel about
the end of the study?
• How do you relate with the participants?
• What are your perceptions on how the participants feel about
the study, and the study team?
• How do non-participants feel about those who participated?
8 How was end of the study communicated, a) to you b) to the
participants c) to the community; what are your views about this
process of communication.
9 What are your plans for the future?
10 Any recommendations
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quotes to show diversity of views and to illuminate the
main themes under discussion.
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The role of benefits in participants’ decisions to join and
stay in studies
All respondents (participants, fieldworkers and researchers)
talked of the various forms of study benefits, and the con-
tribution of those benefits to making the research hap-
pen. Below we draw on the literature to categorise the
benefits provided into direct benefits, indirect/collateral
benefits and aspirational benefits.Direct and indirect benefits to participants
In both case studies, the most common and immediate
reason given for joining the study was the immediate ac-
cess to high quality health care for participants, alongside
describing varied depths of understanding of the research
itself. This is unsurprising since both case studies provided
health care as part of the direct and indirect study bene-
fits to participants (see above) and KEMRI-WT is often
thought of as a hospital.
“…they [researchers] told us that if the child becomes
sick ‘we will come, take the child for treatment and if
we are defeated we will send the child and the mother
to another hospital and the child will be treated and
the mother will be provided with food, then they will
be transported by a vehicle up to here [hospital]. Oh!
These are good things, the luggage is heavy on our
head and someone wants to help. We were pleased
and … I wished I had ten children I would release
(consent) them all to go into the hands of KEMRI”,
(P3/male/Malaria/FGD13).
Previous positive experiences of having been attended
by KEMRI staff either at the health facilities or at the
county hospital were narrated in many of the interviews
in both case studies. Valued positive experiences in-
cluded treatment of critically ill children or other family
members by KEMRI doctors, the concern and attention
those staff gave patients, and relatives being informed about
what was going on even if the patient eventually died.
These experiences were described as having positively
contributed to consent and high retention rates in both
case studies; retention rates of 78% (47/760) households
in the RSV-study and 83% (748/900) participants in the
Malaria-studyf.I decided fast [to join the study] because of the
situation of my child. He was ever sick and I was ever
going to the hospital but did not seem to recover, so
when the CHWs [community health worker] told me
to come and try (join) KEMRI …I said its better I join
and my child is now well and fine. So I am very
grateful… (P2/female/Malaria/FGD14)
That study benefits facilitated retention of participants
was especially clear in the RSV-study, a basic science
non-therapeutic study involving a particularly unpopular
and unfamiliar study procedure, taking a sample of naso-
pharyngeal mucus using a flocked swab. The study team
realised early on in the study that meeting recruitment
targets and retaining nearly 50 entire households in the
study would be difficult given the discomfort of the pro-
cedure. Additional pressure for the study team to meet
recruitment numbers was due to the relatively short dur-
ation of the RSV epidemic (five months), and the possibility
that failure to carry out the study as designed would lead to
extending it to the next epidemic season and to increased
research costs. A comprehensive community engagement
strategy to inform different constituencies about the study -
community leaders, the entire population of the study area,
household heads, and eligible household members - had
been rolled out. This was perceived to have been well
received in the community and facilitated participation.
In addition, provision of relatively simple items such as
sweets to children was highly praised by both FWs and
participants for encouraging participation and helping
calm children and their mothers during nasal swabbing.
Yes, like I don’t know whether to call them benefits
or what but I think those sweets, they used to be seen
like something very small but it contributed in a big
way to the success of this project or this study.
Because the children became calmer… later, I saw that
the adults sometimes liked the sweets maybe even
more than the children … (FW4/male/RSV/FGD06)
Indirect benefits to the wider community
KEMRI-WT was often highly praised for providing high
quality health care compared with the perceived lack-
lustre services of the public health facilities in which trial
activities were based.
“…probably a child is sick at the dispensary, and there
is the KEMRI section and that of the government. So
on the KEMRI section the child gets quick treatment
and the treatment the child gets is that of high
quality…and in our hospitals they do not investigate,
you just tell the doctor how you are feeling and they
just assume its malaria, and give you drugs…”
(P5/male/Malaria/FGD13)
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pared to the surrounding community, long lists of com-
munity needs were presented at community engagement
meetings over the course of the study. While researchers’
and FWs’ general response was to re-explain study re-
quirements and agreed benefits, they were sometimes able
to assist in an emergency. For example in the RSV-study
when a cholera epidemic broke out, researchers provided
emergency aid to the community, including treating all
communal water wells, setting up a temporary emergency
ward at the local health facility, and providing clinical ser-
vices, diagnosis kits, drugs, and ambulatory services for re-
ferrals to the county hospital. In explaining this assistance,
one researcher noted:
“…you can’t see cholera affecting the place and you just
sit back and yet you can do something about it. And
you can’t also say now that only 3 of our participants
have cholera we are only treating those ones. Then
again, if the dispensary lacks paracetamol which is a
very basic drug, and we have [it]; we can afford to get
paracetamol for them, then it’s our social responsibility
to them (community)” (R2/female/RSV/IDI05).
Although the Malaria-study was in a drier area of the
county, with perennial food shortages, negotiations for
different sorts of benefits were less often described in
interviews, compared to the RSV-study. This could be
because KEMRI-WT was new in the area of the
Malaria-study, and hence expectations of what KEMRI-
WT could offer were not as high. It also could be that
informing and providing complete health care for partici-
pating children, and food and transport for participants
and guardians for all clinic visits right from the outset of the
study addressed (see Table 3) the immediate health care
needs for this population. In addition, the intensity of inter-
actions between FWs and households in the RSV-study
(with between 2–4 hours per visit to each participating
household twice a week in the RSV-study) could have gener-
ated different sorts of relationships and expectations (more
kinship-like) which increased pressure for FWs to respond.
Aspirational benefits of the research
Though less often discussed, some participants described
altruistic reasons for joining the studies, which seemed
to refer to the eventual societal benefit should the research
be ‘successful’. They saw their participation in research as
contributing to better health for future generations.
“…malaria has disturbed so many people in this
world, children have been dying at a young age,
mothers miscarry or children die during delivery
because of malaria. So after realizing that there was
research being done for preventing malaria so that itdoes not affect us again, I was really pleased by that
issue; and I said it was better to join so that we make
a contribution for the vaccine to be found
[discovered]…” (P1/male/Malaria/FGD13)
In the Malaria-study, these altruistic reasons for par-
ticipation seemed to be in addition to expectations of
immediate therapeutic benefit from the experimental
vaccine. Thus, positive results of the research were an-
ticipated to benefit both current and future generations,
as explained by one FW:
“All children will benefit [if the study succeeds] but
those who benefit first are the ones who are in the
study, because it’s only when the research is proved to
work, that’s when the others who are not in the study
will benefit” (P6/Female/Malaria/FGD14).
Such high expectations, however, might also have been
parents’ way of reassuring themselves that they made the
right choice in enrolling their children in an experimental
vaccine trial whose outcome was uncertain.
Expanding expectations and demand for more assistance
from participants
There was some shifting of benefits given out over time
in the RSV-study, in an effort to retain participants and
in response to participants (and community) needs and
concerns. Thus chairs were provided to facilitate the taking
of nasal swabs, education materials were given to school
going children, and insecticide treated bed-nets (ITNs)
were distributed to pregnant mothers and all children
aged less than five years in the participating households.
Over time, it became apparent that the study teams’
provision of such benefits and compensations was feeding
into expectations for more.
So with every other household we received very many
expectations yah, even for some families, some would
refuse to be swabbed and tell you, ‘I have a cold, I can’t
make it to the dispensary, why don’t you bring me the
drugs here at home so that you can swab me’. So that
was really difficult for us (R2/female/RSV/IDI05).
Requests for additional benefits included requests for
items that the Ministry of Health (MOH) should pro-
vide. For example, some parents threatened to withdraw
from the study if pre-natal servicesg and male-child cir-
cumcision services were not provided in the RSV- and
the Malaria-study respectively. It was difficult for fieldwor-
kers and researchers in both case studies to know how to
respond to participants’ requests and needs: re-emphasising
study information, as described below, sometimes seemed
inadequate.
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who withdrew the other day, she said that the
moment a participant is recruited or taken by KEMRI
we concentrate so much on the (participating) kid
than the mother or other family members; so there
are some other moments she wishes to be handled or
taken care of herself, or given the attention the kid is
given, but she never gets (FW2/male/Malaria/FGD08).
During our field visits at the end of the RSV-study, we
noticed that many household members requested tokens
of appreciation for having persevered with the study and
possibly also in response to hints from FWs that additional
tokens might be provided.
Negotiating study benefits: a challenge for FWs and
frontline research staff
As already suggested above, despite the value placed on
them by participants, the provision of study benefits ap-
peared to present significant challenges for researchers
and FWs. The study teams, including FWs, knew that
they could not extend benefits without proper guidance
from the research centre (through the community en-
gagement advice team, or CAST), and from the national
KEMRI ERC committee. Some participants’ requests for
benefits such as food, school fees and uniforms, and
shelter, went beyond what the study team, and the re-
search programme, felt they could respond to. Feeling
frustrated, fieldworkers sometimes responded in personal
ways, including through using their own money to buy
food for families. While this provided temporary relief for
the participants, the unanswered issue for researchers and
the research centre was whether there was a need for a
more carefully considered and agreed approach to handle
such emergencies for individual households.
With regards to extending benefits and emergency
support to individuals, a contested area was whether
those already participating in research could be unduly
influenced through provision of more and different sorts
of benefits. Some researchers felt strongly that enrolled
participants could not be unduly influenced as they had
already weighed up the risks and benefits for participa-
tion. They felt that undue inducement arguments were
sometimes used to reduce or deny participants benefits:
“…if I were to decide for this study about the benefits
to be given, having been at these households, I would
have a very long list of cheap things we can give the
households and they would appreciate. Although I
know it would be like we are inducing them to
participate in the study but they are already
participating in the study, so I don’t think introducing
extra benefits at this time would have much effect on
their participation…” (R2/female/RSV/IDI02)Some argued that given the relative wealth of the insti-
tution, the long-term presence of the research centre in
this community, and the high poverty levels and unmet
health needs among the community, studies should give
more benefits to participants and communities.
“…but that issue (of additional benefits for
participants) kept coming up, I think, in practically all
of our meetings…and in the long run, each one of us
who actually got into contact with those participants
or within those households, I think we all felt that we
did not give enough… This is a big study, they
(participants) have made it succeed, it’s them who have
made it a success, so we should also be able to give
them something tangible” (R2/female/RSV/IDI05).
Other researchers felt that one way to avoid undue
inducement was to give additional benefits to whole
communities rather than individuals. A dilemma, where
emphasis was placed on community-level benefits, is that
participants might be unwilling to participate unless they
also receive separate forms of benefits.
“…I believe the idea of balancing (risks and benefits)
is trying to ensure that people don’t participate in
your study just because of the benefits, but again you
have to understand people cannot participate in the
study if there are no benefits” (R1/male/RSV/IDI01).
One researcher in the RSV-study, who was also a
member of the community engagement advisory team
(CAST) for the study, strongly supported provision of
more benefits to participants and the broader commu-
nity. This researcher was the link between the FWs and
the study PIs. She accompanied FWs to the field almost
every day, and supported the clinical team during home
visits. She was particularly frustrated by institutional
limitations of what to offer the community, especially
when the advice appeared misaligned with livelihood
struggles for most households at a time of drought and
famine. The field team estimated that nearly half of the
community required some form of food aid over the
study period, and requested to provide food items to
participating households as part of study compensation
for the considerable time taken in follow-up visits. After
reviewing the situation, the CAST group advised against
the request on the grounds that it was not within the
overall mandate and focus of the research centre, and
because of concerns of intra-community inequity if
non-participating households were not also given food
rations. Other arguments were that giving food rations
in that context might unduly influence participants to
join or stay in the study without a good understanding
of the research, that future smaller studies could not
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research in neighbouring areas may face similar demands
that cannot be met at that time due to budgetary limita-
tions. The researcher sounded particularly frustrated with
these arguments:
“…we have tried to forward these (requests for
additional benefits) to the CAST team and tried to
justify every small thing we give, but every other time
we do so in our CAST meeting, we are told again we
can’t (give more benefits). You know, you go there
wishing you could be allowed to take a packet of flour
to the household, but again our hands are tied”
(R2/female/RSV/IDI05).
Fieldworkers and frontline researchers as gatekeepers to
benefits for community members
Based on study protocols and job descriptions, FWs
were not expected to negotiate research benefits with
participants. However, FWs were the immediate link
between the participants and the researchers through
which information and requests were communicated. In
this intermediary role, FWs seemed to mediate the type
and nature of information that was passed on, choosing
how information was framed and what was emphasised.
As FWs said, they were the ones who often delivered
study benefits and tokens of appreciation to participants;
they attended to participants at the health facility,
helping them fill the various forms, manoeuvre through
bureaucracies and ensure access to quick services. It
was therefore inevitable that participants would per-
ceive FWs as conduits for study benefits; the people
they needed to talk to and negotiate with first. This was
described in an FGD with FWs and repeated in other
interviews:
FW5: You are the person who goes there handing
over those things (benefits) to them. (FW3 interrupts)
FW3: And you give the information yourself and
whenever they come here, when they want to get the
benefit, it’s you they meet and it’s like whenever they
meet you everything goes smoothly.
FW4: When they see us, it’s like they have met the
benefits!
(FW/RSV/FGD07)
For some FWs, working for the research centre was a
means by which they could help improve the livelihood
of the community. During DK’s field observation, she re-
ported that most FWs strongly felt that assisting partici-
pants and the community gain benefits, especially health
care for the really poor households, was one way of
helping those households; they seemed to view their role
as helping these families alleviate some of their healthcare burdens. Convincing the researchers to provide
additional benefits and to respond to other needs of
these participants and the community was one way in
which the Research Centre, and hence also the fieldwor-
kers, could be seen to be valuable to the community.
Given the daily livelihood struggles that fieldworkers en-
countered among some participants, the main issue for
fieldworkers was not about undue inducement (which
seemed abstract) but about responding to these needs.
While FWs were delighted when their requests to in-
crease benefits for participants were accepted, they were
also aware of intra-household and intra-community jeal-
ousies that could stem from unequal distribution of such
benefits. Sometimes these tensions seemed to work in
the FWs’ favour particularly where some ‘difficult’ partic-
ipants later regretted refusing the study. This strength-
ened, at least temporarily, participants and FW status
vis-a-vis non-participants. FWs were also concerned that
complex impact of studies on social relations within
households and communities might continue and shift
after the study ends:
We don’t know what will happen (when the study
ends), but what I think is that their relationship
[participants and non-participants] at first may not be
good, because if somebody had gotten used to being
attended to quickly when they get here [dispensary],
so their colleagues used to be jealous; now this time
when they come and they all queue, there may be
some exchange of words … (FW4/Male/RSV/FGD06)
Discussion
This paper highlights the complexities arising in negoti-
ating for research participation, particularly between
fieldworkers and participants, and the centrality of bene-
fits in those negotiations. We have presented the voices
and experiences of those who are most affected by policies
and decisions of ERCs but who are rarely consulted in
benefit discussions; the fieldworkers, research participants
and researchers at the frontline of research implementa-
tion. There are some limitations to point out. Firstly, the
study was not designed to explore benefits; rather the
issue of benefits emerged as a theme in a broader social
science study that was looking at the nature of interac-
tions between fieldworkers and participants in two
community-based studies. Secondly, and relatedly, we
are hesitant to make normative claims based on this rela-
tively small study. Nevertheless this paper makes a contri-
bution to wider debates on how benefits are negotiated on
the ground, and is feeding into on-going in-depth consul-
tations on benefits in Kilifi that will inform local policy.
This paper also highlights the issues - many unaddressed
in current guidelines - that staff at the frontline of research
implementation face in relation to benefits, particularly
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vantaged populations. It is these issues that the following
sections address.
Study benefits facilitating participant retention in research
As has been widely documented in this setting and
elsewhere, study benefits, and especially health care,
appeared to greatly influence participants’ decisions to
join and stay in the study [26-29]. This is unsurprising
in our setting given that many households are quite far
from public health care facilities, and that many of
these facilities are understaffed, face drug stock-outs,
and impose charges [30,31]. Therefore what might ap-
pear to be relatively small benefits for facilities or
households (the RSV-study), or indeed large ones (the
Malaria-study) can have a significant positive impact
on households, such as better care, reduced costs and
more accessible health care services. Even small provi-
sions such as sweets and refunds of transport costs are
described as benefits and apparently contribute to
decision-making surrounding study participation. A
challenge is that the information about a study, includ-
ing risks and inconveniences, may ‘crowd out’ [32] in-
formation about, discussions and negotiations over
benefits; participants may focus on information about
benefits rather than other study information if benefits
are their immediate priority. Where benefits are in-
creased over the course of a study in response to
requests, individuals may also join future studies in the
same area with the expectation that benefits can be
negotiated and increased. In both of these scenarios,
consent processes may be undermined and – where
participants agree to procedures they would otherwise
have rejected – there could be concerns of undue
inducement [19]. Community engagement is one ap-
proach to clarifying the role and different components
of research, and how it differs from routine health care.
However it may be an inadequate response in a context
of such poverty. Employing FWs from the community
assists with having a group who can relate to communities
at a personal level, and their long term presence in the
community can contribute to greater mutual understand-
ing, including regarding what benefits are and why they
are provided in research. However this is clearly an
ethically and emotionally demanding position for FWs,
as discussed more below.
Types and level of research benefits: a continuing
challenge for research in developing countries
It became apparent in this study that the appropriate
types and levels of benefits, and to whom such benefits
should be provided, were key challenges facing frontline
research staff. In particularly, it was not clear how to
respond to requests for humanitarian assistance whenthese were unanticipated. While there were no easy
responses to these issues, some researchers preferred
adhering to ‘rules’ as outlined in their approved study
protocols, whilst others felt some flexibility should be
allowed in practice. In certain situations, concerns of
undue inducement were perceived to be too narrow a
concern when faced with poverty and famine.
These local level debates echo elements of international
benefit sharing and ancillary care debates [10,33], and of
recent debates among researchers at the Programme [22].
Some argue that research and research participation
should primarily be based on goodwill, altruism, and part-
nership, and aim to avoid costs to participants and a com-
mercial relationship [13,34,35]. Others argue that research
should maximise participants’ benefits given the relative
wealth of the research institution and multiple community
needs [10,36-38]. As evidenced in this research, there are
no easy answers to these issues. Based on the findings of
this research, and the literature on the role of the duration
and intensity of relationships between researchers and
study participants being important in influencing re-
searcher’s responsibilities [10,39], there are strong ethical
arguments that a long term relatively wealthy research
centre hosted in a poor community should respond to
background inequities and humanitarian emergencies that
exacerbate vulnerability of these populations. This could
be done through programme-wide and study specific
strategies. Working closely with relevant government
agencies would be one way of responding to these
background inequities, as is currently happening at the
research programme, and as described earlier in this
paper in relation to the Ministry of Health. However a
particular challenge for many researchers including in
our setting is how to respond to unmet needs not
related to health, where lack of relevant expertise fea-
tures alongside other concerns related to establishing
boundaries around these responsibilities [40], a point
we revisit later in this discussion.
At the KEMRI-WT programme, an approach that has
informally evolved to respond to background inequities
has been to supplement individual benefits with the
provision primarily of medical benefits to whole com-
munities. This is primarily through collaborations with
the Ministry of Health to support sustainability, as well
as individual benefits to participants [41]. This compromise,
it is hoped, minimises risks of undue inducement for indi-
vidual participants, protects community harmony, avoids a
commercial relationship with participants, and protects and
strengthens a key relationship of health researchers with
the MOH. This approach is potentially one way to tackle
micro-level justice issues [10] in a way that recognises
macro-level justice concerns. It is recognised however that
this could only ever be one of a set of approaches to benefit
sharing at both the micro- and macro-levels. On-going
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discourses. Findings from this study support consider-
ation of both community and participant benefits, and
of health and non-health benefits especially in cases of
emergency humanitarian need. To mobilize resources to
support this, one approach proposed by Ballantyne et al.
is to levy different infrastructural charge rates for industry
and non-industry funded research [13], a proposal that
could be explored.
Implications for fieldworker roles
In this study, it became apparent that fieldworkers were
‘agitating’ for increased benefits to participants partly
out of empathy for the livelihood needs of some of the
participants, out of good ‘neighbourliness’ as part of
social support, and to advance their self-interests (for
example, advance their status in the community, or meet
recruitment targets). Fieldworkers appearing to overly
encourage research participation through emphasis on
study benefits can also be seen as responding to real
needs of their own communities, in contexts of unmet
health needs and underperforming health care systems,
as has also been described previously in this setting and
elsewhere [12,16,42-44]. The challenge is where such
support is felt as pressure by participants to join or
remain in research, or as the fieldworker - rather than
the participant - effectively making the decision to partici-
pate in research. FWs’ approach to responding to partici-
pants’ (and community) needs could also be perceived as
indicating conflicting motivations; to meet recruitment
quotas versus to respond to humanitarian situations they
encountered. FWs may not have always perceived these
motivations as potentially ethically conflicting, but rather
as complementary in practice: encouraging participation
both improved their study success rate in terms of recruit-
ment rates, and ensured that participants could access
health care services and other study benefits. FW some-
times described this as an ‘honourable’ thing to do as they
‘brought development’ to their communities, but it also
appeared to strengthen the FWs’ status in the community.
It could also be that some FWs were under-supported
to unpack and carefully consider the range of potential
ethical dilemmas that could arise in their everyday in-
teractions with participants, and possible responses.
This strengthens the call for appropriate support to
FW and frontline research staff, as discussed below.
Such support would be responsive to the context in
which FWs work, and could be systematized across the
research institution. It could, for example, include skill-
building and knowledge-based support (such as training
on communication skills, basic research ethics principles),
interactive sessions that draw on FWs field experiences to
identify and unpack ethical challenges and dilemmas, and
more broadly changing the culture of team interactions tosupport open discussions of issues that could otherwise be
perceived as individual failures at work. These and other
initiatives could be considered as contributing towards
developing ethical mindfulness among research staff [43],
including a critical awareness at all levels of their multiple
roles and identities. Perceptions of researcher and field-
worker roles and identities may not be shared with com-
munity members, and this might contribute to ethically
challenging moments in research work.
One recent suggestion from the research centre to facili-
tate flexibility on the ground and to provide a response
system for FWs facing unexpected pressing ethical con-
cerns is to adopt a ‘tsunami fund’ or some form of allow-
ance for FWs, with guidelines on its use [22]. As the
authors note, this has its own potential to raise new prob-
lems including sourcing and accounting for such funds,
establishing fair and equitable systems for FWs to distrib-
ute such benefits, possible unexpected or unintended im-
pacts on power relations between FWs and participants,
and reducing households’ ability to refuse or withdraw
from the study. Moreover, such short-term strategies
might leave families worse-off post-study by displacing
some other forms of support that families draw upon.
Another strategy, potentially a more acceptable ap-
proach, is to link such support to other institutions
with remit to provide similar assistance such as NGOs,
government departments, and CBOs operating in the
area. A challenge, however, is the ability and sustain-
ability of those institutions. The dilemma therefore
remains: how far should researchers go in addressing
real needs of community (beyond health-related needs)
and how should they do this in ways that do not leave
the community in precarious situations at the end of
such support?
The importance of advisory systems to studies during
research implementation
For approved research protocols which allow flexibility
on the ground, a continuing challenge for many researchers
is guidance on which other types of benefits, above those
directly related to the research, to provide. One approach
seen as valuable at the research centre is to establish advis-
ory teams for studies (CAST) to guide on unanticipated
ethical issues during research implementation. Guidelines
on the role and mandate of CAST were formulated, to
also safeguard against potential to usurp ERC power and
authority. Thus, the CAST supplements institutional and
national ERCs in advising on levels and types of benefits
being offered by individual studies, given that ERCs at na-
tional level are often unable to take into account local
day-to-day issues and concerns. By sticking to guidelines
and study protocols, some of the CAST members were
sometimes perceived to be unresponsive to ground real-
ities, even though CAST are only supposed to advice, with
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hand by being too flexible, there were concerns that the
CAST would lose the objectivity necessary to offer appro-
priate advice. We found that the CAST played a critical
role in providing this objective view, but also that they
needed to allow some reasoned flexibility. One approach
would be for CAST members independent of the study
team to accompany FWs in field visits, and make inde-
pendent assessments of field situations. While it is import-
ant to involve FWs as one group to consult with, it places
too large a burden on them in contexts where they are in-
tensely emotionally involved in individual and household
needs. their insider knowledge, however, is valuable in
informing the decisions that may be taken. The roles of
ERC remain crucial in advising on the actions being con-
sidered. The ancillary care framework could provide some
guidance, where flexibility is possible, on the type and
range of benefits as it provides an argument for why
researchers might have a responsibility to offer more
support in this type of study and context, especially
where unpredicted challenges are faced [33]. Having a
responsive CAST group or equivalent is one approach
to support benefit negotiations at the local level to supple-
ment national approaches and accommodate flexibility on
the ground. Such groups would then need careful under-
standing of when decisions need to be checked with
national bodies.
Conclusion
The issues that this paper raises may be similar in other
settings, where research is conducted by relatively wealthy
research institutions among low income populations.
Debates about researchers and research organizations’
responsibilities in extreme situations of poverty and
unmet health needs among host communities increas-
ingly filter into debates on ethical research conduct in
developing countries. However the voices of those who
find themselves - inevitably because of their interface
position - negotiating for research participation, and
who often face these situations upfront, the fieldwor-
kers and frontline research staff, are rarely included in
such debates. This paper describes the morally imbued
work of such staff, and the ethical dilemmas they face work-
ing in developing country settings. Beyond providing appro-
priate support for such staff to be able to respond in these
circumstances, we suggest the need for more specific tar-
geted empirical work around how well the current guide-
lines and frameworks on research benefits are working in
developing country settings; and empirically informed argu-
ments for researchers and research institutions’ responsibil-
ities and the limits of these. Current on-going community
consultation work at the research centre, with range of
stakeholders including community members and field-
workers, is aimed at providing some guidance on this area.Endnotes
aAs of November 2011.
bThe SFWs in the two case studies were not direct
supervisors of FWs, but had roles that required more
experience such as counterchecking quality of samples
collected and delivering samples from field to main la-
boratory offices.
cWhile the Malaria-study had about 400 participants by
the time of this research, we excluded about 220 house-
holds from the list of potential participants for this research
as they were involved in another social science study which
some questions similar to those asked in this study. We se-
lected the 30 households for observation based on diversity
of locality, of FWs allocated to the households and rota of
field visits for FWs.
dAs indicated in Table 1, the case studies had other re-
searchers apart from the PI. Coordinators and managers
are included in this study as ‘researchers’ because they
were involved in developing and implementing the research
protocol.
eThis was informed by our experiences of natural group
discussions in the RSV-study, in which we noticed that
female household members tended to talk less, would
often verbally agree with views of the male-members,
while sometimes non-verbally seeming to disagree.
fThe figure is cumulative of 75% in the 5-17 months
age-group and 95% in the 6–12 weeks age-group of par-
ticipants in the Malaria-study who were participating at
the time of conducting this social science study.
gPrenatal and antenatal services are ideally provided free
at the public health facilities; however mothers attending
these services often queue for long. They also pay referral
costs in case of complications.
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